GATC Health’s Revolutionary Drug Discovery Platform Creates Novel Addiction Molecule in Less Than Three Months

With a patent application filed for the molecule, the company moves forward with pre-Investigational New Drug Application (IND) testing and development

IRVINE, Calif., Jan. 28, 2022 -- GATC Health Corp, a technology company revolutionizing drug discovery and disease prediction using artificial intelligence and advanced multiomics, today announced it has created a new compound the company believes could address a number of treatment-resistant addictions, including cocaine and methamphetamine. The in silico molecule design was completed in less than three months after receiving biological sample data and biomarker indicators.

“This work provides further evidence that our Multiomics Advanced Technology™ (MAT) platform has the potential to substantially reduce drug discovery timelines and costs,” noted GATC Health’s Chief Scientific Officer, Ian Jenkins. “By creating this new molecule using our platform’s virtual human modeling, we believe we have taken a significant step towards eliminating the ‘AI Gap.’ Traditional methods of drug discovery, and even current AI-enhanced methods, deliver thousands of molecules that need to be individually tested to find the one which will become a new drug. We believe this could be the first known instance of an in silico process creating the exact drug candidate molecule, eliminating the time and expense of testing thousands of incorrect targets.”

The company is moving forward with pre-IND testing and development and will provide further information regarding this addiction treatment molecule and its drug discovery platform in the near future.

*   *   *

About GATC HealthGATC Health Corp is a pioneering technology company using whole genome analysis and multiomics-based artificial intelligence to revolutionize disease detection and drug discovery. The company’s patented AI platform reduces risk, time and costs for life science companies by digitally reproducing the human body to find non-obvious answers to biology’s most complex questions. GATC Health is accelerating healthcare’s transition to predictive, individualized medicine.Disclaimer

The information set forth herein is presented for informational purposes only and should not be deemed an offer to sell securities.  This presentation contains information which the Company believes to be correct, including certain financial information and projections, but the Company does not guarantee as to the accuracy or completeness of such information.  The Company reserves the right to modify or amend the information contained herein.